Interpreting clinical trials in lung cancer: impact of methodology and endpoints.
about
Quality of life assessment as a predictor of survival in non-small cell lung cancerPrognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancerEndpoints in advanced breast cancer: methodological aspects & clinical implications.Expanding the repertoire of RNA interference screens for developing new anticancer drug targets.Quality of life research in neuro-oncology: a quantitative comparison.Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer?Docetaxel in the treatment of non-small cell lung carcinoma: an update and analysisReporting trends of outcome measures in phase II and phase III trials conducted in advanced-stage non-small-cell lung cancer.Association between changes in quality of life scores and survival in non-small cell lung cancer patients.
P2860
Q33993427-8C789EBD-27D6-4865-B874-E305F2EA1B27Q35142686-A7F30000-1FBE-4806-AF06-A993B70D3148Q35611036-B9BF295F-8242-4306-B623-8AA0F00386BAQ37008841-CBAD5647-DA0B-47DB-8EC0-DE84623F57EBQ38159965-36DF13BE-453A-4506-9915-8CF132311304Q38389980-6E03800A-557A-4C3F-9B24-16BA20FAC9FDQ39139831-B8AD4E38-C155-466B-8B2D-F1F8C2717F3BQ46255750-8DBFD8E2-507D-4B9D-A74F-897A48D3195FQ48487145-EE805E5B-EF2F-4D69-B291-601E63DACAB5
P2860
Interpreting clinical trials in lung cancer: impact of methodology and endpoints.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Interpreting clinical trials in lung cancer: impact of methodology and endpoints.
@en
type
label
Interpreting clinical trials in lung cancer: impact of methodology and endpoints.
@en
prefLabel
Interpreting clinical trials in lung cancer: impact of methodology and endpoints.
@en
P1476
Interpreting clinical trials in lung cancer: impact of methodology and endpoints.
@en
P2093
Frank Griesinger
Richard J Gralla
P356
10.1097/01.JTO.0000269734.27047.3E
P478
P577
2007-06-01T00:00:00Z